Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ian Frank

7PUBLICATIONS
140CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInnate immunityPacific Peoples social, cultural, emotional and spiritual wellbeingMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks, Zoe Moodie, Mary A Allen

|Apr 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).

Sharon A Riddler, Zoe Moodie, Jesse Clark

|Sep 05, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.

William O Hahn, K Rachael Parks, Mingchao Shen

|Dec 06, 2021
Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.

Shelly Karuna, Shuying Sue Li, Shannon Grant

|Oct 14, 2021
mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.

Rishi R Goel, Mark M Painter, Sokratis A Apostolidis

|Jun 03, 2018
Identification and characterization of HIV-specific resident memory CD8<sup>+</sup> T cells in human lymphoid tissue.

Marcus Buggert, Son Nguyen, Gonzalo Salgado-Montes de Oca

Pageof 2

Frequent Collaborators

4 joint publications

David Montefiori

3 joint publications

Mary Allen

3 joint publications

Lawrence Corey

3 joint publications

Stephen R Walsh

2 joint publications

Kelly E Seaton

2 joint publications

Michael R Betts

2 joint publications

K Rachael Parks

2 joint publications

E John Wherry

2 joint publications

Leticia Kuri-Cervantes

2 joint publications

Laura A Vella

Frequent Collaborators

4 joint publications

David Montefiori

3 joint publications

Mary Allen

3 joint publications

Lawrence Corey

3 joint publications

Stephen R Walsh

Top Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on : Feb 10, 2022

3.7K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on : Dec 03, 2019

8.9K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on : May 06, 2015

10.4K
See more related videos

Top Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on : Feb 10, 2022

3.7K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on : Dec 03, 2019

8.9K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on : May 06, 2015

10.4K
See more related videos